Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Fish and Richardson
US Army
Medtronic
Argus Health
Accenture
Julphar
Deloitte
Colorcon

Generated: December 15, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR BUPRENORPHINE

« Back to Dashboard

Clinical Trials for Buprenorphine

Trial ID Title Status Sponsor Phase Summary
NCT00000200 Cocaine Effects in Humans: Physiology and Behavior - 1 Completed Columbia University Phase 2 The purpose of this study is to compare the effects of buprenorphine or methadone maintenance on cocaine taking and on the physiological and subjective effects of cocaine, including cocaine craving, in opiate-dependent cocaine users.
NCT00000200 Cocaine Effects in Humans: Physiology and Behavior - 1 Completed National Institute on Drug Abuse (NIDA) Phase 2 The purpose of this study is to compare the effects of buprenorphine or methadone maintenance on cocaine taking and on the physiological and subjective effects of cocaine, including cocaine craving, in opiate-dependent cocaine users.
NCT00000202 Buprenorphine Maintenance for Opioid Addicts - 1 Completed National Institute on Drug Abuse (NIDA) Phase 2 The purpose of this study is to evaluate the efficacy of buprenorphine and desipramine in treatment of opiate and cocaine dependence.
NCT00000202 Buprenorphine Maintenance for Opioid Addicts - 1 Completed Yale University Phase 2 The purpose of this study is to evaluate the efficacy of buprenorphine and desipramine in treatment of opiate and cocaine dependence.
NCT00000203 Buprenorphine Maintenance for Opioid Addicts - 2 Completed National Institute on Drug Abuse (NIDA) Phase 2 The purpose of this study is to evaluate varying doses of buprenorphine for opioid dependence and cocaine abuse.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Buprenorphine

Condition Name

Condition Name for Buprenorphine
Intervention Trials
Opioid-Related Disorders 89
Opioid Dependence 30
Heroin Dependence 30
Opiate Dependence 22
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Buprenorphine
Intervention Trials
Opioid-Related Disorders 137
Substance-Related Disorders 39
Heroin Dependence 33
Disease 27
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Buprenorphine

Trials by Country

Trials by Country for Buprenorphine
Location Trials
Japan 29
United Kingdom 26
Germany 9
Malaysia 7
Norway 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Buprenorphine
Location Trials
New York 70
California 62
Florida 57
Pennsylvania 50
Maryland 49
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Buprenorphine

Clinical Trial Phase

Clinical Trial Phase for Buprenorphine
Clinical Trial Phase Trials
Phase 4 57
Phase 3 88
Phase 2/Phase 3 8
[disabled in preview] 106
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Buprenorphine
Clinical Trial Phase Trials
Completed 234
Recruiting 35
Terminated 28
[disabled in preview] 45
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Buprenorphine

Sponsor Name

Sponsor Name for Buprenorphine
Sponsor Trials
National Institute on Drug Abuse (NIDA) 129
Purdue Pharma LP 27
Yale University 26
[disabled in preview] 46
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Buprenorphine
Sponsor Trials
Other 290
Industry 154
NIH 136
[disabled in preview] 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Johnson and Johnson
Colorcon
AstraZeneca
Chinese Patent Office
Farmers Insurance
Medtronic
Moodys
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.